MedTrace Logo

Hydrogel Blister Patch Prototype Treatment for Foot Blisters on the Heel

NCT01088685 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2011-10-06

No results posted yet for this study

Summary

Study to evaluate the safety and performance of a new blister patch intended to treat blisters on the heel of the foot.

Conditions

  • Blister

Interventions

DEVICE

Experimental Blister Patch

Experimental hydrogel blister patch to be applied as needed (at least every 2 days) consecutively until blister heals

DEVICE

Marketed Pflaster

Foot Blister Patch to be applied as needed (at least every 2 days) until blister heals

Sponsors & Collaborators

  • Johnson & Johnson Consumer and Personal Products Worldwide

    lead INDUSTRY

Principal Investigators

  • Qing Li, PhD · J&J Consumer and Personal Products Worldwide

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01088685 on ClinicalTrials.gov